Author: Anthony Rume

By Gift Briton There is hope in the fight against Tuberculosis (TB) following the launch of Phase 3 clinical trials of a new vaccine candidate that could prevent pulmonary TB in adolescents and adults. Bill and Melinda Gates Medical Research Institute (Gates MRI), which sponsors the clinical trial, announced the launch, noting that the Phase 3 clinical trial will assess the efficacy of the new TB vaccine candidate named M72/AS01E. “The launch of this pivotal Phase 3 trial demonstrates our commitment to harnessing the power of medical innovation to fight diseases like TB that are particularly devastating for low- and…

Read More